MARWYNN HOLDINGS, INC. (MWYN) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-07-31..
- Stock-based compensation / revenue · 12 months: Value 2.21%; Formula and calculation Share-based compensation / revenue. Period ending 2026-07-31..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-07-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-07-31. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 2.21% | Share-based compensation / revenue. Period ending 2026-07-31. $117.17K ÷ $5.29M × 100 ≈ 2.21% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 5.29M USD | |
| Stock-based compensation | 117.17K USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -730.77K USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-31 | (m) | $5.29M | $117.17K | $-730.77K | (m) | (m) | 2.21% | (m) | (m) |
| 2026-04-30 | (m) | $4.24M | $117.17K | $-3.28M | (m) | (m) | 2.76% | (m) | (m) |
| 2026-01-31 | (m) | $11.81M | (m) | $-7.20M | (m) | (m) | (m) | (m) | (m) |
| 2025-10-31 | (m) | $11.05M | (m) | $-6.57M | (m) | (m) | (m) | (m) | (m) |
| 2025-07-31 | (m) | $10.61M | (m) | $-6.85M | (m) | (m) | (m) | (m) | (m) |
| 2025-04-30 | (m) | $11.11M | $90.08K | $-4.37M | (m) | (m) | 0.81% | (m) | (m) |
| 2025-01-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-04-30 | (m) | $11.92M | (m) | $1.39M | (m) | (m) | (m) | (m) | (m) |
| 2024-01-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMCON DISTRIBUTING CO (DIT) | United States | $0.066B | 39.54 |
| UNITED NATURAL FOODS INC (UNFI) | United States | $2.783B | 36.48 |
| Chefs' Warehouse, Inc. (CHEF) | United States | $4.502B | 30.54 |
| Performance Food Group Co (PFGC) | United States | $14.229B | 47.99 |